Skip to main content
Premium Trial:

Request an Annual Quote

Prometheus to Use DNA Genotek Kits for Celiac Disease Risk Test

NEW YORK (GenomeWeb News) – DNA Genotek said today that Prometheus will use its sample-collection kits for a saliva-based genetic test for celiac disease.

Under the agreement, Prometheus will use DNA Genotek's Oragene DNA kit, a non-invasive DNA self-collection method, to collect saliva samples for the MyCeliacID test.

The DNA-based test is designed to detect variations in the DQ gene that are specific to celiac disease in order to estimate individual risk.

Celiac disease affects around 3 million Americans, the company said, but only around 100,000 cases are diagnosed.

The MyCeliacID test is currently available in most parts of the US, Canada, and Mexico, the company said. Patients order the test online and send the sample to Prometheus' CLIA lab for analysis. Test results are available online via a secure link.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.